Lymphomatoid Granulomatosis Workup
- Author: Nader Kamangar, MD, FACP, FCCP, FCCM; Chief Editor: Zab Mosenifar, MD, FACP, FCCP more...
No characteristic laboratory abnormalities exist in lymphomatoid granulomatosis.
Obtain a WBC count.
- Leukopenia (20%) and lymphopenia (33%) may be present.
- CD4 lymphocyte count may be low.
- Leukocytosis greater than 10,000 cells/μ L is rare.
Hematocrit is normal or slightly elevated.
Erythrocyte sedimentation rate (ESR) has mild-to-moderate elevation but may be normal.
Obtain renal and liver function studies. Findings are usually normal.
Urinalysis results are usually normal.
Delayed-type hypersensitivity and lack of anergy have been reported in more than 50% of cases.
Obtain chest radiographs. Results are usually abnormal but nonspecific. The radiologic differential diagnosis for lymphomatoid granulomatosis includes pseudolymphoma, malignant lymphoma, lymphocytic interstitial pneumonia, metastasis, sarcoidosis, Wegener granulomatosis, and cryptogenic organizing pneumonia. Some lesions regress, while others progress. Chest radiograph lesions and abnormalities include the following:
Bilateral nodules or masses in the lower and peripheral lung fields (80-100%). These nodules may occasionally be migratory in nature.
Pleural effusions (33%)
Pneumonitis or large masslike lesion (30%)
Cavitation of nodules (30%)
See the image below.
Hilar and mediastinal lymphadenopathy are rare and should prompt consideration of an alternative diagnosis or raise concern of transformation into aggressive lymphoma. Airway disease can involve the following:
Distal small airway
Main bronchial disease (occasionally)
Atelectasis or lobar collapse on chest films
Radiographic differential diagnoses can include the following:
Primary pulmonary and metastatic malignancy
Granulomatous diseases, including WG and sarcoidosis
Perform a chest CT scan. The role of CT scan requires further study. CT scan better defines pulmonary lesions, but findings are nonspecific. CT scan is useful for monitoring disease progression and response to treatment.
See the images below.
Perform brain imaging. CT scan shows high-density lesions. MRI lesions are isointense or hyperintense on T1-weighted images and hyperintense on T2-weighted images. Enhancement may be punctate and linear, a finding that can be relatively specific for inflammation of deep cerebral vessels.
Perform a tissue diagnosis.
In general, perform a biopsy on the most accessible organ involved.
Establishing the diagnosis of lymphomatoid granulomatosis usually requires an open lung or video-assisted thoracoscopic biopsy. Transbronchial lung biopsy has not been studied rigorously. Because of the focal nature of lymphomatoid granulomatosis and the fact that it is not bronchocentric, a low diagnostic yield with bronchoscopic transbronchial biopsies is likely. In one study, the diagnosis was established with the aid of open lung biopsy in 70% of cases, bronchoscopic lung biopsy in 15% of cases, and extrapulmonary biopsy in 15% of cases. In cases where bronchoscopic lung biopsy is nondiagnostic, a thoracoscopic lung biopsy may be necessary.
Skin biopsy is the least invasive.
In all cases, inform the pathologist that lymphomatoid granulomatosis is clinically suspected to ensure that appropriate studies are performed.
A definitive diagnosis of lymphomatoid granulomatosis requires the presence of the following histological triad:
Polymorphic lymphocytic infiltrate
Granulomatosis (central necrosis)
A nodular perivascular infiltrate containing plasma cells, lymphocytes, and large atypical mononuclear cells in various stages of maturity is present. This is a destructive lesion due to vessel occlusion by lymphocytic infiltration and subsequent tissue necrosis.
Perform analysis for cell phenotype, clonality, and EBV infection. As discussed above, despite the predominance of T cells, the malignant cells appear to be B cells, and the T-cell infiltrate is polyclonal (see Pathophysiology). In general, the B-cell population is clonally expanded; however, oligoclonal populations have been identified in rare cases. A similar finding is described in posttransplant lymphoma and probably reflects an EBV-related phenomenon.
When peripheral nerve involvement exists, the infiltrate surrounds the nerve and causes spotty demyelination.
Gangar P, Venkatarajan S. Granulomatous Lymphoproliferative Disorders: Granulomatous Slack Skin and Lymphomatoid Granulomatosis. Dermatol Clin. 2015 Jul. 33 (3):489-96. [Medline].
Liebow AA, Carrington CR, Friedman PJ. Lymphomatoid granulomatosis. Hum Pathol. 1972 Dec. 3(4):457-558. [Medline].
Araki F, Mimura T, Fukuoka S, et al. Primary orbital lymphomatoid granulomatosis. Br J Ophthalmol. 2009 Apr. 93(4):554-6. [Medline].
Pereira AC, Oliveira TM, Nomelini RS, Saldanha JC, Calil MC, Murta EF. Lymphomatoid granulomatosis of the vulva: case report with immunohistochemical analysis. J Obstet Gynaecol. 2009 Apr. 29(3):255-6. [Medline].
Canovas D, Vinas J, Martinez J, Viguera M, Estela J, Ribera G. [Lymphomatoid granulomatosis with exclusively neurological involvement.]. Neurologia. 2009 Mar. 24(2):140-1. [Medline].
Lucantoni C, De Bonis P, Doglietto F, et al. Primary cerebral lymphomatoid granulomatosis: report of four cases and literature review. J Neurooncol. 2009 Mar 26. [Medline].
Lemieux J, Bernier V, Martel N, Delage R. Autologous hematopoietic stem cell transplantation for refractory lymphomatoid granulomatosis. Hematology. 2002 Dec. 7(6):355-8. [Medline].
Rao R, Vugman G, Leslie WT, Loew J, Venugopal P. Lymphomatoid granulomatosis treated with rituximab and chemotherapy. Clin Adv Hematol Oncol. 2003 Nov. 1(11):658-60; discussion 660. [Medline].
Wilson WH, Kingma DW, Raffeld M, Wittes RE, Jaffe ES. Association of lymphomatoid granulomatosis with Epstein-Barr viral infection of B lymphocytes and response to interferon-alpha 2b. Blood. 1996 Jun 1. 87(11):4531-7. [Medline].
Polizzotto MN, Dawson MA, Opat SS. Failure of rituximab monotherapy in lymphomatoid granulomatosis. Eur J Haematol. 2005 Aug. 75(2):172-3. [Medline].
Castrale C, El Haggan W, Chapon F, Reman O, Lobbedez T, Ryckelynck JP, et al. Lymphomatoid granulomatosis treated successfully with rituximab in a renal transplant patient. J Transplant. 2011. 2011:865957. [Medline]. [Full Text].
Cervera P, Guihot A, Gorochov G, Lassoued K, Coppo P. Epstein-Barr virus-driven B Cell Proliferation with CD4(+) T Cell Expansion: A Lymphomatoid Granulomatosis-like Disease Related to Hyperinterleukin-10 Secretion of Remarkably Favourable Outcome with Rituximab. Scand J Immunol. 2015 Dec. 82 (6):532-8. [Medline].
Barakat A, Grover K, Peshin R. Rituximab for pulmonary lymphomatoid granulomatosis which developed as a complication of methotrexate and azathioprine therapy for rheumatoid arthritis. Springerplus. 2014. 3:751. [Medline].
Jordan K, Grothey A, Grothe W, Kegel T, Wolf HH, Schmoll HJ. Successful treatment of mediastinal lymphomatoid granulomatosis with rituximab monotherapy. Eur J Haematol. 2005 Mar. 74(3):263-6. [Medline].
Sebire NJ, Haselden S, Malone M, Davies EG, Ramsay AD. Isolated EBV lymphoproliferative disease in a child with Wiskott-Aldrich syndrome manifesting as cutaneous lymphomatoid granulomatosis and responsive to anti-CD20 immunotherapy. J Clin Pathol. 2003 Jul. 56(7):555-7. [Medline].
Zaidi A, Kampalath B, Peltier WL, Vesole DH. Successful treatment of systemic and central nervous system lymphomatoid granulomatosis with rituximab. Leuk Lymphoma. 2004 Apr. 45(4):777-80. [Medline].
Jaffre S, Jardin F, Dominique S, Duet E, Hubscher P, Genevois A. Fatal haemoptysis in a case of lymphomatoid granulomatosis treated with rituximab. Eur Respir J. 2006 Mar. 27(3):644-6. [Medline].
Ishiura H, Morikawa M, Hamada M, Watanabe T, Kako S, Chiba S, et al. Lymphomatoid granulomatosis involving central nervous system successfully treated with rituximab alone. Arch Neurol. 2008 May. 65(5):662-5. [Medline].
Bolaman Z, Kadiköylü G, Polatli M, Barutca S, Culhaci N, Sentürk T. Migratory nodules in the lung: lymphomatoid granulomatosis. Leuk Lymphoma. 2003 Jan. 44(1):197-200. [Medline].
Katzenstein AL, Carrington CB, Liebow AA. Lymphomatoid granulomatosis: a clinicopathologic study of 152 cases. Cancer. 1979 Jan. 43(1):360-73. [Medline].
McNiff JM, Cooper D, Howe G, Crotty PL, Tallini G, Crouch J, et al. Lymphomatoid granulomatosis of the skin and lung. An angiocentric T-cell-rich B-cell lymphoproliferative disorder. Arch Dermatol. 1996 Dec. 132(12):1464-70. [Medline].
Myers JL. Lymphomatoid granulomatosis: past, present, ... future?. Mayo Clin Proc. 1990 Feb. 65(2):274-8. [Medline].
Wu SM, Min Y, Ostrzega N, Clements PJ, Wong AL. Lymphomatoid granulomatosis: a rare mimicker of vasculitis. J Rheumatol. 2005 Nov. 32(11):2242-5. [Medline].